531 results on '"Hróbjartsson, Asbjørn"'
Search Results
2. Commercial Funding and Estimated Intervention Effects in Randomized Clinical Trials: Systematic Review of Meta-Epidemiological Studies
3. Methods used to develop the SPIRIT 2024 and CONSORT 2024 Statements
4. A tool to assess risk of bias in non-randomized follow-up studies of exposure effects (ROBINS-E)
5. Shall we count the living or the dead?
6. A framework for the definition and interpretation of the use of surrogate endpoints in interventional trials
7. Combining Meta-Epidemiological Study Datasets on Commercial Funding of Randomised Clinical Trials: Database, Methods, and Descriptive Results of the COMFIT Study
8. A structured approach to information retrieval improved identification of funding and researchers’ conflicts of interest in trials included in Cochrane reviews
9. A meta-epidemiological study found that meta-analyses of the same trials may obtain drastically conflicting results
10. Reporting Biases
11. A scoping review identifies multiple comments suggesting modifications to SPIRIT 2013 and CONSORT 2010
12. A scoping review finds that guides to authors of protocols for observational epidemiological studies varied highly in format and content
13. An update to SPIRIT and CONSORT reporting guidelines to enhance transparency in randomized trials
14. Development of a topic‐specific bibliographic database supporting the updates of SPIRIT 2013 and CONSORT 2010
15. Adherence to the PRISMA-P 2015 reporting guideline was inadequate in systematic review protocols
16. The methodological quality was low and conclusions discordant for meta-analyses comparing proximal humerus fracture treatments: a meta-epidemiological study
17. Ten Questions to Consider When Interpreting Results of a Meta-Epidemiological Study--The MetaBLIND Study as a Case
18. Association between conflicts of interest and favourable recommendations in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews : systematic review
19. Critical reading of systematic review articles
20. Declaración PRISMA 2020: una guía actualizada para la publicación de revisiones sistemáticas
21. Impact of blinding on estimated treatment effects in randomised clinical trials : meta-epidemiological study
22. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
23. Research response to coronavirus disease 2019 needed better coordination and collaboration: a living mapping of registered trials
24. Agreement was moderate between data-based and opinion-based assessments of biases affecting randomized trials within meta-analyses
25. Controversy and Debate on Meta-epidemiology. Paper 1: Treatment effect sizes vary in randomized trials depending on the type of outcome measure
26. Postponement of Death by Pharmacological Heart Failure Treatment: A Meta-Analysis of Randomized Clinical Trials
27. Systematic review finds that appraisal tools for medical research studies address conflicts of interest superficially
28. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
29. ROB-ME: a tool for assessing risk of bias due to missing evidence in systematic reviews with meta-analysis
30. RoB 2 : a revised tool for assessing risk of bias in randomised trials
31. Reporting Biases
32. Minimum clinically important differences in chronic pain vary considerably by baseline pain and methodological factors: systematic review of empirical studies
33. Postponement of Death by Statin Use: a Systematic Review and Meta-analysis of Randomized Clinical Trials
34. Interleukin-6 blocking agents for treating COVID-19: a living systematic review
35. Meta-epidemiology and the MetaBLIND study: Response to Tack
36. Active placebo control groups of pharmacological interventions were rarely used but merited serious consideration: a methodological overview
37. Unreported formal assessment of unblinding occurred in 4 of 10 randomized clinical trials, unreported loss of blinding in 1 of 10 trials
38. European Society Paediatric Gastroenterology, Hepatology and Nutrition Guidelines for Diagnosing Coeliac Disease 2020
39. Financial conflicts of interest in clinical research
40. Impact of active placebo controls on estimated drug effects in randomised trials: a systematic review of trials with both active placebo and standard placebo
41. Using Risk of Bias 2 to assess results from randomised controlled trials: guidance from Cochrane
42. A Framework for the Definition and Interpretation of the Use of Surrogate Endpoints in Interventional Trials’
43. A new classification of spin in systematic reviews and meta-analyses was developed and ranked according to the severity
44. Exploration of factors associated with adequacy of reporting of randomised trial protocols and complete publications: systematic review of studies on adherence to the SPIRIT 2013 and CONSORT 2010 reporting guidelines
45. Response to Soares et al.
46. A systematic review found no consistent difference in effect between more and less intensive placebo interventions
47. A declaração PRISMA 2020: diretriz atualizada para relatar revisões sistemáticas
48. Efficacy and safety of COVID-19 vaccines
49. Commercial funding and estimated intervention effects in randomized clinical trials: Systematic review of meta‐epidemiological studies
50. The evolving context of reporting randomised trials. A scoping review of comments on SPIRIT 2013 and CONSORT 2010
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.